Pursuant to Regulation 30 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 and with reference to Board meeting dated August 29, 2019, Lasa Supergenerics has informed that allotment committee of the Board of Directors of the company have allotted 1,78,08,219 equity shares of company to the promoter of the company. In-principal approval under regulation 28(1) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 received from the exchanges through their letter dated November 07, 2019 and November 29, 2019 respectively.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: